Been on one for many months TH with little effect.
UTR report has been supportive but Intelligent Investor seems to have kicked it along today.
New Management is obviously the key long term apart from 'tip sheets'.
But any bounce is welcomed regardless of how it's achieved at this stage.
- Forums
- ASX - By Stock
- Ann: Change of Director's Interest Notice
Been on one for many months TH with little effect. UTR report...
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MVP (ASX) to my watchlist
|
|||||
Last
41.0¢ |
Change
0.010(2.50%) |
Mkt cap ! $42.82M |
Open | High | Low | Value | Volume |
40.0¢ | 42.0¢ | 40.0¢ | $11.76K | 28.71K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9403 | 41.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 18006 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9403 | 0.410 |
1 | 25000 | 0.405 |
5 | 58306 | 0.400 |
1 | 20000 | 0.395 |
2 | 25277 | 0.390 |
Price($) | Vol. | No. |
---|---|---|
0.420 | 18006 | 3 |
0.425 | 10000 | 1 |
0.450 | 90 | 1 |
0.460 | 7300 | 1 |
0.470 | 2000 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
MVP (ASX) Chart |